Ľuboš Drgoňa

5.0k total citations
53 papers, 1.4k citations indexed

About

Ľuboš Drgoňa is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Ľuboš Drgoňa has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Epidemiology and 14 papers in Infectious Diseases. Recurrent topics in Ľuboš Drgoňa's work include Neutropenia and Cancer Infections (16 papers), Antifungal resistance and susceptibility (10 papers) and Fungal Infections and Studies (10 papers). Ľuboš Drgoňa is often cited by papers focused on Neutropenia and Cancer Infections (16 papers), Antifungal resistance and susceptibility (10 papers) and Fungal Infections and Studies (10 papers). Ľuboš Drgoňa collaborates with scholars based in Slovakia, United States and Czechia. Ľuboš Drgoňa's co-authors include Michal Mego, Giuseppe Ippolito, Carlota Gudiol, Vladimír Zajac, Małgorzata Mikulska, Murat Akova, Bernd Salzberger, Simone Lanini, Soňa Čierniková and George Dimοpoulos and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Ľuboš Drgoňa

48 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ľuboš Drgoňa Slovakia 17 636 574 403 391 181 53 1.4k
Sejal Morjaria United States 12 748 1.2× 363 0.6× 324 0.8× 815 2.1× 161 0.9× 36 1.6k
Athanasios Tragiannidis Greece 19 589 0.9× 586 1.0× 180 0.4× 241 0.6× 131 0.7× 89 1.5k
Jessica Galloway-Peña United States 22 554 0.9× 290 0.5× 237 0.6× 590 1.5× 137 0.8× 43 1.3k
J. Guitard France 26 637 1.0× 627 1.1× 144 0.4× 194 0.5× 142 0.8× 89 1.6k
Krista Dubin United States 8 691 1.1× 296 0.5× 766 1.9× 1.1k 2.7× 172 1.0× 9 2.0k
Jean‐San Chia Taiwan 29 221 0.3× 516 0.9× 198 0.5× 481 1.2× 129 0.7× 75 1.9k
John W. Hiemenz United States 14 1.4k 2.1× 1.3k 2.2× 322 0.8× 141 0.4× 156 0.9× 28 2.0k
Ming‐Fang Cheng Taiwan 19 397 0.6× 377 0.7× 144 0.4× 277 0.7× 128 0.7× 81 1.3k
Jonathan U. Peled United States 21 587 0.9× 339 0.6× 379 0.9× 1.1k 2.9× 117 0.6× 74 2.0k
Sabine Mousset Germany 19 532 0.8× 638 1.1× 325 0.8× 97 0.2× 100 0.6× 39 1.3k

Countries citing papers authored by Ľuboš Drgoňa

Since Specialization
Citations

This map shows the geographic impact of Ľuboš Drgoňa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ľuboš Drgoňa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ľuboš Drgoňa more than expected).

Fields of papers citing papers by Ľuboš Drgoňa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ľuboš Drgoňa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ľuboš Drgoňa. The network helps show where Ľuboš Drgoňa may publish in the future.

Co-authorship network of co-authors of Ľuboš Drgoňa

This figure shows the co-authorship network connecting the top 25 collaborators of Ľuboš Drgoňa. A scholar is included among the top collaborators of Ľuboš Drgoňa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ľuboš Drgoňa. Ľuboš Drgoňa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cholujová, Dana, et al.. (2025). CyTOF profiling of bone marrow immune dynamics across myeloma stages. OncoImmunology. 14(1). 2542333–2542333.
2.
Čierniková, Soňa, Aneta Ševčíková, Ľuboš Drgoňa, & Michal Mego. (2023). Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(6). 188990–188990. 34 indexed citations
3.
Cholujová, Dana, Zachary R. Hunter, Teru Hideshima, et al.. (2022). Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia. International Journal of Cancer. 152(9). 1947–1963. 5 indexed citations
4.
Babela, R., et al.. (2021). Economic aspects of multiple myeloma: real costs associated with disease in the Slovak Republic. Neoplasma. 68(2). 454–464. 2 indexed citations
5.
6.
Lengerová, Martina, Iva Kocmanová, Ľuboš Drgoňa, et al.. (2018). Detection and identification of fungi in bronchoalveolar lavage fluid from immunocompromised patients using panfungal PCR. Folia Microbiologica. 64(3). 421–428. 6 indexed citations
7.
Mikušková, Eva Ballová, et al.. (2018). A unique clinical presentation of de novo acute promyelocytic leukemia as a myeloid sarcoma of the breast. International Journal of Hematology. 108(5). 550–553. 3 indexed citations
8.
Mego, Michal, Jozef Chovanec, Mária Rečková, et al.. (2015). Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study. Complementary Therapies in Medicine. 23(3). 356–362. 180 indexed citations
9.
Mego, Michal, et al.. (2013). Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy. Complementary Therapies in Medicine. 21(6). 712–723. 81 indexed citations
10.
Drgoňa, Ľuboš, et al.. (2013). Triggers for driving treatment of at-risk patients with invasive fungal disease. Journal of Antimicrobial Chemotherapy. 68(suppl 3). iii17–iii24. 1 indexed citations
11.
Ráčil, Zdeněk, Martina Tošková, Iva Kocmanová, et al.. (2012). Micafungin as empirical antifungal therapy in hematological patients: a retrospective, multicenter study in the Czech and Slovak Republics. Leukemia & lymphoma. 54(5). 1042–1047. 5 indexed citations
12.
Drgoňa, Ľuboš, J. Trupl, & Helena Hupková. (2010). Clinical analysis of 92 patients with Fungaemia - data from national survey in Slovakia. International Journal of Infectious Diseases. 14. e125–e126. 1 indexed citations
13.
Mego, Michal, Eva Ballová Mikušková, Ľuboš Drgoňa, et al.. (2005). Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study. Supportive Care in Cancer. 14(3). 285–290. 30 indexed citations
14.
Špánik, S., et al.. (1996). Bloodstream infections due to anaerobic bacteria in cancer patients: epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia.. PubMed. 43(4). 235–8. 11 indexed citations
15.
Špánik, S., J. Trupl, Ľuboš Drgoňa, et al.. (1996). Bacteremia and Fungemia Occurring during Antimicrobial Prophylaxis with Ofloxacin in Cancer Patients: Risk Factors, Etiology and Outcome. Journal of Chemotherapy. 8(5). 387–393. 3 indexed citations
16.
Drgoňa, Ľuboš, et al.. (1996). Ofloxacin Once Daily versus Twice Daily in Community-Acquired Pneumonia and Acute Exacerbation of Chronic Bronchitis. Chemotherapy. 42(3). 227–230. 2 indexed citations
17.
Oravcová, E., E. Kukučková, V. Krčméry, et al.. (1996). Funguria in cancer patients: Analysis of risk factors, clinical presentation and outcome in 50 patients. Infection. 24(4). 319–323. 18 indexed citations
18.
Špánik, S., V. Krčméry, J. Trupl, et al.. (1996). Breakthrough bacteraemic and fungaemic episodes during antimicrobial prophylaxis and therapy in cancer patients: analysis of risk factors, etiology, therapy and outcome in 123 episodes.. PubMed. 97(11). 652–9. 1 indexed citations
19.
20.
Trupl, J., et al.. (1993). Fungal Pathogens in Etiology of Septic Shock in Neutropenic Patients with Cancer (Short Communication). Zentralblatt für Bakteriologie. 278(4). 562–565. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sejal Morjaria Breakdown of academic impact, for papers by Athanasios Tragiannidis Breakdown of academic impact, for papers by Jessica Galloway-Peña Breakdown of academic impact, for papers by J. Guitard Breakdown of academic impact, for papers by Krista Dubin Breakdown of academic impact, for papers by Jean‐San Chia Breakdown of academic impact, for papers by John W. Hiemenz Breakdown of academic impact, for papers by Ming‐Fang Cheng Breakdown of academic impact, for papers by Jonathan U. Peled Breakdown of academic impact, for papers by Sabine Mousset
Rankless by CCL
2026